Clinical Trial

A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy of SHR-A2102 with adebrelimab versus gemcitabine in combination with cisplatin/carboplatin in previously untreated locally advanced or metastatic urothelial carcinoma.
Protocol Amendment History 3 changes
minor Trial arms changed: 3 -> 2 2026-08-15
notable Primary completion pushed: 2027-09 -> 2028-01-31 2026-08-15
minor Completion pushed: 2030-06 -> 2030-10-31 2026-08-15
Trial Details
NCT Number NCT07393542
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Locally Advanced or Metastatic Urothelial Carcinoma
Enrollment 453 participants
Start Date 2026-02-12
Primary Completion 2028-01-31 (estimated)
Study Completion 2030-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14